About this Journal Submit a Manuscript Table of Contents
Biochemistry Research International
Volume 2011 (2011), Article ID 901572, 7 pages
http://dx.doi.org/10.1155/2011/901572
Research Article

Hsp27-Actin Interaction

Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02472, USA

Received 29 April 2011; Accepted 11 July 2011

Academic Editor: Stefano Gianni

Copyright © 2011 Philip Graceffa. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Hsp27 oligomer is reported to interact with F-actin as a barbed-end-capping protein. The present study determined the binding strength and stoichiometry of the interaction using fluorescence of probes attached to Hsp27 cysteine-137. The fluorescence of acrylodan attached to Hsp27 increased 4-5-fold upon interaction with F-actin. Titration of the fluorescence with F-actin yielded a weak binding constant ( ) with an actin/Hsp27 stoichiometry between < 1 and 6. This stoichiometry is inconsistent with an F-actin end-capping protein. Pyrene attached to Hsp27 exhibited a large excimer fluorescence, in agreement with the known proximity of the cysteine-137's in the Hsp27 oligomer. Upon interaction with F-actin the pyrene-Hsp27 excimer fluorescence was largely lost, suggesting that Hsp27 interacts with F-actin as a monomer, consistent with the acrylodan-Hsp27 results. EM images of F-actin-Hsp27 demonstrated that Hsp27 is not a strong G-actin sequester. Thus, Hsp27, in vitro, is a weak F-actin side-binding protein.

1. Introduction

Mammalian heat shock protein 27 (Hsp27) is a member of a family of small heat shock proteins that includes the eye lens protein αB-crystallin, the archetype of the family [13]. These proteins form oligomeric structures and share a conserved α-crystallin domain responsible for intersubunit β-strand-β-strand interactions in the basic dimer subunit. Under physiological conditions Hsp27 occurs as a polydisperse distribution of oligomers centered about a minimum 22mer [4]. Hsp27 is involved in a variety of cellular functions including molecular chaperone activity, control of apoptosis, and regulation of the actin filament cytoskeleton [13, 59].

Actin is one of the most abundant proteins, that is present in almost all eukaryotic cells. The actin filament (F-actin) is composed of actin monomers (G-actin) polymerized head-to-tail to form two intertwining helical strands, resulting in a polar filament with a “barbed end” and a “pointed end” [10]. Actin filaments are part of the cytoskeleton and their dynamic structure is involved in the motility and shape change of the cell [10]. Hsp27 has been implicated in numerous physiological and pathological processes that involve its interaction with actin and its control of actin dynamics [1125]. However, the mechanism of the interaction between Hsp27 and actin is unclear and controversial and a binding study of the interaction between the two proteins in vitro has not been reported [3]. An early study of the Hsp25 (murine and avian isoform of Hsp27)—actin interaction concluded that Hsp25 was an actin filament barbed-end-capping protein based on limited evidence [26]. Since that study it has generally been assumed that Hsp25 and Hsp27 are actin barbed-end-capping proteins, although there has been little further support for this interaction model. It is also unknown if Hsp27 interacts with the actin filament as a monomer, dimer, or higher multimer.

In order to address some of these issues we have investigated the interaction between Hsp27 and actin, in vitro, using fluorescence probes attached to Hsp27. We concluded that Hsp27, although an oligomer in solution, binds to the actin filament, most likely, as a monomer, with an actin monomer/Hsp27 molar stoichiometry between <1 and 6. Such a stoichiometry does not support the view that Hsp27 is simply an actin filament end-capping protein. Instead, we propose that Hsp27 binds along the side of the F-actin filament.

2. Materials and Methods

2.1. Preparation of Hsp27 and Actin

Full-length Hsp27 was prepared by bacterial expression and purification using the New England Biolabs IMPACT-CN intein system, as described previously [4]. The advantage of using the intein expression system is that no extraneous N- or C-terminal residues are introduced. Additional N-terminal amino acids in expressed Hsp27 have been shown to alter the oligomeric structure of Hsp27 and other small heat shock proteins [27, 28]. The purified Hsp27 was concentrated by Millipore/Amicon Ultra centrifugal filter devices, then dialyzed and stored on ice in 2 mM Mops, 0.1 mM EDTA, 0.01% NaN3, 50  M PMSF, pH 7.5 (Buffer A). Hsp27 concentration was determined from the absorbance at 280 nm, after subtracting the absorbance at 320 nm, using an extinction coefficient of . Actin was prepared as reported [29] from rabbit skeletal muscle and stored for up to two weeks on ice as the actin monomer in G-buffer (2 mM Mops, 0.2 mM CaCl2, 0.2 mM ATP, 0.01% NaN3, pH 7.5). Actin concentration was determined from the absorbance at 290 nm minus that at 320 nm using an extinction coefficient [30]. G-actin was polymerized to F-actin by adding NaCl and MgCl2 to 40 mM and 2 mM, respectively (F-buffer).

2.2. Fluorescence Labeling of Hsp27

The sulfhydryl reactive fluorescent probes acrylodan (6-acryloyl-2-(dimethylamino)naphthalene) (AC) and pyrene iodoacetamide (N-(1-pyrene)iodoacetamide) were purchased from Molecular Probes (Invitrogen). The single cysteine (Cys137) of Hsp27 was labeled with the above probes for several hours at 37°C as described for other probes [31]. Briefly, Hsp27 in Buffer A was reacted with a 2.5-fold molar excess of acrylodan for 3 hr or a 10-fold molar excess of pyrene-iodoacetamide for 5 hr at 37°C. The reaction was stopped with 5 mM DTT, followed by dialysis versus Buffer A to remove dissolved excess label, after centrifuging pyrene-Hsp27 to pellet the suspended, unreacted pyrene-iodoacetamide probe. The labeling ratios were determined by measuring the labeled Hsp27 concentration with the BCA protein assay [32] using unlabeled Hsp27 as a standard and measuring the attached acrylodan and pyrene concentrations from the optical absorbance with extinction coefficients ε360 nm = 12,900 M−1cm−1 [33] and ε343 nm = 22,000 M−1cm−1 [34], respectively. The final molar labeling ratios (probe/Hsp27) were between 0.6–1.0 for pyrene-Hsp27 and 0.8–1.1 for acrylodan-hsp27.

2.3. Hsp27-Actin Interaction by Fluorescence Spectroscopy

Fluorescence measurements were made on a Varian Eclipse fluorometer equipped with a Varian Peltier device for temperature control. Fluorescence measurements of acrylodan-Hsp27 and pyrene-Hsp27 were made at excitation wavelengths of 395 nm and 342 nm, respectively. For fluorescence titration of acrylodan-Hsp27 with F-actin at different concentrations, separate samples were made up for each titration point and incubated overnight at 37°C before spectra were recorded. From the spectra, the fluorescence intensity was determined at 485 nm and plotted versus the total actin concentration.

The data are analyzed according to a simple binding equation, nA + B = AnB where A is the actin protomer in F-actin, B is Hsp27 irrespective of its oligomeric state, and n is the actin/Hsp27 molar binding stoichiometry. The binding is described by the equation: nb 2 − (KD+ nb + a) + a = 0 where b is the total concentration of Hsp27 which is held constant, a is the total concentration of actin which is varied, KD is the dissociation constant, and is the fractional saturation of binding sites, i.e. [AB]/nb, which is equal to the fractional increase in fluorescence enhancement and is a root of the quadratic solution to the above equation. One can extract n and KD by fitting a quadratic solution to the binding equation to the data points using an unweighted, nonlinear least squares fitting procedure [35, 36].

2.4. Electron Microscopy of F-Actin ± Hsp27

F-actin at 150  M was diluted to 2  M in F-buffer. To some samples Hsp27 was added to 6  M and incubated for 120 min at room temperature, followed by overnight at 4°C and 120 min at room temperature. Samples were then applied to a carbon-film coated copper grid, negatively stained with 1% aqueous uranyl acetate and observed under a Philips 300 electron microscope at 60 kV.

2.5. Analytical Ultracentrifugation

Analytical ultracentrifugation sedimentation velocity was run and the resulting data was analyzed as described [4].

3. Results

The direct binding of a protein to F-actin filaments is generally determined by cosedimentation of the filaments with bound protein, followed by SDS-PAGE of the pellet and supernatant. However, Hsp27 is a large oligomeric protein which also sediments, independently of actin binding, making this technique problematic. Therefore we took an alternative approach by using Hsp27 labeled with a fluorescence probe whose signal is sensitive to the binding of actin. Two cysteine-specific fluorescence probes, acrylodan and pyrene-iodoacetamide, attached to the single cysteine (Cys137) of Hsp27 fulfilled this requirement.

3.1. Acrylodan-HSP27

In order to determine the effect of the acrylodan probe on Hsp27 quaternary structure, analytical ultracentrifugation sedimentation velocity of acrylodan-Hsp27 (AC-Hsp27) was compared to that of unlabeled Hsp27 over a range of concentrations (Figure 1). No significant difference was found. Both labeled and unlabeled Hsp27 had almost identical sedimentation coefficients of close to 20 svedbergs (Figure 1), a value in agreement with our previous conclusion that Hsp27 is an oligomeric distribution centered around a minimum size of a 22-mer [4]. Thus placing a probe at Cys137 does not significantly perturb the oligomeric structure of Hsp27.

901572.fig.001
Figure 1: Weight average sedimentation coefficient, corrected to 20°C in water, versus concentration of Hsp27 (closed circles) or AC-Hsp27 (open squares). Buffer = 120 mM NaCl, 25 mM Tris, 2 mM MgCl2, 0.2 mM EGTA, 0.01% NaN3, 50  M PMSF, 5 mM DTT, and pH 7.5. The standard deviation of the data points is propagated from the noise in the original data set as described [37].

Acrylodan is very sensitive to its environment [33] and, when attached to a protein, often sensitive to protein-protein interaction. As shown in Figure 2, acrylodan-Hsp27 is very sensitive to the binding to F-actin. In the presence of actin the fluorescence intensity increased about 4-5-fold and the emission spectrum was blue-shifted about 20 nm (Figure 2), changes indicative of greater probe shielding from the solvent upon interaction with actin.

901572.fig.002
Figure 2: Effect of F-actin on the fluorescence spectrum of AC-Hsp27. AC-Hsp27 (1  M) at 37°C in F-buffer in the absence (closed circles) and presence (open circles) of 40  M F-actin after overnight incubation at 37°C.

In order to determine the strength and stoichiometry of the binding, the fluorescence enhancement of a fixed concentration of acrylodan-Hsp27 was titrated with increasing concentrations of F-actin at 37°C. For this determination acrylodan-Hsp27 was incubated with F-actin overnight at 37°C in order to insure complete equilibration. This was necessary since upon addition of F-actin to acrylodan-Hsp27 the acrylodan fluorescence increased slowly after an initial relatively rapid rise (Figure 3). After overnight at 37°C there was no further change in fluorescence intensity for at least 5 hours. The slow equilibration could be best fit with two exponentials (Figure 3) suggesting that at least two processes are taking place.

901572.fig.003
Figure 3: Fluorescence versus time of AC-Hsp27 plus F-actin. Fluorescence at 485 nm of 1  M AC-Hsp27 versus time after addition of 40  M F-actin in F-buffer at 37°C. The saturated fluorescence value of 432 ± 6 fluorescence units was obtained from an unweighted, nonlinear least squares double exponential fit of the data points and the root mean square deviation of the points from the fit.

The titration of acrylodan-Hsp27 fluorescence intensity with F-actin was best fit with an apparent dissociation constant of = 5.3  M ± 0.6 (Figure 4), fixing the actin/Hsp27 molar stoichiometry at 1.0, indicating a rather weak interaction. Because the Hsp27-actin binding is not strong, the stoichiometry is somewhat uncertain in that the data can be fit with an actin/Hsp27 molar stoichiometry value of between <1 and 6 with a 90% confidence level using F-statistics on values. The dissociation constant varies between 3.0 and 5.6  M over this range of stoichiometries. The fit deteriorates for stoichiometries of greater than 6 in that values continue to increase. These results indicate that Hsp27 binds to actin all along the actin filament, each Hsp27 monomer interacting with between <1 and 6 actin subunits. Indeed, Hsp27 is an elongated molecule [4] which could well cover at least two actin subunits. A stoichiometry of less than 1 would indicate several Hsp27 molecules interacting with each actin molecule in the actin filament. This latter situation would be limited by physical crowding of Hsp27 molecules along the filament.

901572.fig.004
Figure 4: Fluorescence of AC-Hsp27 titrated with F-actin. Percent fluorescence enhancement at 485 nm as a function of actin concentration in F-buffer at 37°C. AC-Hsp27 = 1  M. The best fit of the data yielded an apparent dissociation constant M with the actin/Hsp27 molar stoichiometry fixed at 1.0. The error in is calculated from the root mean square deviation of data points from the fit.

These results rule out that Hsp27 is binding to actin simply as a barbed-end-capping protein. The average length of an actin filament polymerized in vitro is about 6.7 μm [38], equivalent to about 2500 actin subunits. Thus an Hsp27 22-mer [4] bound at the barbed end of each filament would result in an actin/Hsp27 molar stoichiometry of greater than 100. For smaller oligomers the stoichiometry would be higher, all values much larger than we have estimated from the fluorescence titration in Figure 4.

3.2. Pyrene-HSP27

Although we have ruled out that Hsp27 binds to actin simply as an end-capping protein from the acrylodan-Hsp27 results, the results do not allow us to know the size of the Hsp27 that is bound to actin. That is, does it bind to actin as a monomer, a dimer, or a larger multimer? We have used the fluorescence of pyrene-Hsp27 to aid us in this determination. The pyrene probe can be a proximity probe, in that when two pyrene moieties are in close proximity they may stack in the excited state which results in an excited state dimer, called an excimer. Pyrene excimer fluorescence is a broad band centered around 500 nm, quite different from the narrower doublet band of the pyrene monomer moiety centered at about 400 nm [39, 40].

Cys137 of Hsp27 (Cys141 of Hsp25) has been shown to be close to Cys137 of a neighboring Hsp27 molecule in the basic dimeric building block of the Hsp27 oligomer by spin-spin ESR spectroscopy [41, 42] and by disulfide cross-linking [26, 4244]. We thought that we might be able to exploit pyrene excimer fluorescence to monitor this interaction. In agreement with this proximity the fluorescence spectrum of pyrene-Hsp27 showed a relatively intense excimer band compared to that of the band of the pyrene monomer (Figure 5). Upon interaction with F-actin the intensity of the excimer fluorescence of pyrene-Hsp27 dropped dramatically with a smaller concomitant increase in that of the pyrene monomer (Figure 5). The remaining excimer fluorescence in the presence of actin is most likely due to pyrene-Hsp27 that is not bound to actin since the 5-fold molar excess of actin used in this experiment is not sufficient to complex all of the Hsp27 (Figure 4). The concentration of F-actin used was limited by its Rayleigh light scattering which overlaps with the pyrene monomer band. Therefore it is clear that, upon binding of pyrene-Hsp27 to F-actin, the excimer fluorescence is almost entirely lost and this loss is most likely due to a dissociation of pyrene-Hsp27 into monomer molecules attached to actin and thus no longer able to form excimers. These results, together with those of AC-Hsp27, are consistent with Hsp27 binding to actin as a monomer with an actin/Hsp27 molar stoichiometry between <1 and 6.

901572.fig.005
Figure 5: Fluorescence spectrum of pyrene-Hsp27 upon interaction with F-actin. Pyrene-Hsp27 (1  M) in the absence (blue closed circles) and presence (red open circles) of 5-fold molar excess of F-actin at 37°C in F-buffer.

However we cannot entirely rule out that the loss in pyrene-Hsp27 excimer fluorescence upon actin binding is due to a conformational change around Cys137 such that pyrene moieties are no longer able to properly stack for excimer formation. In that case the results would also be consistent with a pyrene-Hsp27 binding to F-actin as a dimer or a multimer with the loss of excimer due to a long-range allosteric conformational change in Hsp27 resulting in the loss of excimer.

3.3. Electron Microscopy of the Actin-HSP27 Complex

It has been concluded from indirect evidence that Hsp27 is a strong actin monomer sequestering protein [24]. It was calculated that 3-4 actin monomers bound tightly to each Hsp27 monomer within the Hsp27 oligomer, with a dissociation constant of 20 nM [24] at 25°C. In order to rule out such an interaction accounting for our findings we observed electron microscopic images of F-actin filaments in the absence and presence of a threefold molar excess of Hsp27 under the F-actin ionic conditions used above. Strong Hsp27 sequestration of actin monomers in equilibrium with actin filaments would result in a dissolution of the filaments upon incubation of the filaments with Hsp27. Our electron microscopic images (Figure 6) showed that, although Hsp27 results in some aggregation of F-actin filaments, there is no significant dissolution of the filaments, indicating no significant actin monomer sequestration by Hsp27. Thus such a mechanism cannot account for our fluorescence observations above.

fig6
Figure 6: Electron microscopy of F-actin ± Hsp27. Negative staining images of 2  M actin (a) and 2  M actin plus 6  M Hsp27 (b) incubated overnight in F-buffer. Magnification equals x 15960. Images courtesy of Dr. Katsuhide Mabuchi.

4. Discussion

This study investigated the equilibrium binding parameters of the in vitro interaction between Hsp27 and F-actin and concluded that, in vitro, Hsp27 is not a simple actin barbed-end-capping protein, as is generally assumed. Rather, it is concluded that Hsp27 binds weakly along the side of the actin filament as a monomer with an actin/Hsp27 molar ratio between <1 and 6. A previous work also concluded that monomeric but not oligomeric Hsp25 interacted with actin [45]. However, we cannot entirely rule out that Hsp27 is a barbed-end-capping protein in addition to being an actin side-binding protein, which has been shown to be the case for another actin-binding protein, vinculin [46].

The fitting of the binding data assumes a rather simple binding model of Hsp27 monomer in solution in equilibrium with actin-bound Hsp27. However, Hsp27 is primarily an oligomer in solution [4]; therefore the apparent dissociation constant from the fit reflects the difference in binding between Hsp27 monomer bound to the oligomer compared to its binding to the actin filament. Thus we can only conclude that Hsp27 binds weakly to actin compared to its binding to itself in the Hsp27 oligomer. The strong binding of Hsp27 to itself might reflect a slow rate of dissociation of the monomer (or dimer) from the Hsp27 oligomer and account, at least in part, for the slow attainment of equilibrium of its binding to actin. Alternatively, the first step in the binding sequence might be the attachment of the Hsp27 oligomer to the actin filament which then slowly “peels off” Hsp27 monomers.

Another work has also concluded that Hsp27 is not a barbed-end-capping protein by the effect of Hsp27 on actin polymerization properties [24]. That work concluded that Hsp27 is primarily a strong actin monomer sequestering protein, tightly binding 3-4 actin monomers per Hsp27 molecule in the Hsp27 oligomer [24]. However, our electron microscopic images of F-actin plus Hsp27 demonstrate that Hsp27 does not dissolve actin filaments and thus is not a strong actin monomer sequestering protein. Another recent work has also concluded, from actin polymerization studies, that Hsp27 is inefficient in sequestering actin monomers in the presence of actin filaments [47]. That work [47] and the present work employ Hsp27 without any extra residues at either end of the molecule whereas the previous work [24] used Hsp27 with extra residues at the N-terminus. It has been shown that extra N-terminal residues can modify the oligomeric structure of Hsp27 and other similar small heat shock proteins and thus possibly modify its function [27, 28]. This might be the source of the above discrepancies.

In conclusion, in vitro, Hsp27 is not a simple barbed-end-capping protein but instead primarily binds to the sides of the actin filament. Compared to its binding to itself in the Hsp27 oligomer, Hsp27 binds weakly to actin. The functional consequence of such a weak and slow-to-reach-equilibrium interaction awaits further investigation.

Abbreviations

Hsp27:Heat shock protein 27
DTT:Dithiothreitol
Mops:3-(N-morpholino)propanesulfonic acid
PMSF:Phenylmethylsulfonyl fluoride
Acrylodan:6-acryloyl-2-(dimethylamino)naphthalene
Acrylodan-Hsp27 or AC-Hsp27:Hsp27 labeled with acrylodan
Pyrene Iodoacetamide:(N-(1-pyrene)iodoacetamide)
Pyrene-Hsp27:Hsp27 labeled with pyrene iodoacetamide
a.u.:Arbitrary units.

Acknowledgments

The author wishes to gratefully acknowledge the Electron Microscopy work and images provided by Dr. Katsuhide Mabuchi, the technical assistance of Vanessa Napoli in the preparation of Hsp27, the performance and analysis of the analytical ultracentrifugation experiments by Dr. David Hayes, help with data analysis by Drs. Zenon Grabarek and Walter Stafford, and a critical reading of the paper by Dr. Grabarek. This paper was supported by National Institutes of Health Grant R01 HL 66219.

References

  1. R. Van Montfort, C. Slingsby, and E. Vierling, “Structure and function of the small heat shock protein/α-crystallin family of molecular chaperones,” Advances in Protein Chemistry, vol. 59, pp. 105–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Mounier and A. P. Arrigo, “Actin cytoskeleton and small heat shock proteins: how do they interact?” Cell Stress and Chaperones, vol. 7, no. 2, pp. 167–176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. N. B. Gusev, N. V. Bogatcheva, and S. B. Marston, “Structure and properties of small heat shock proteins (sHsp) and their interaction with cytoskeleton proteins,” Biochemistry (Moscow), vol. 67, no. 5, pp. 511–519, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Hayes, V. Napoli, A. Mazurkie, W. F. Stafford, and P. Graceffa, “Phosphorylation dependence of Hsp27 multimeric size and molecular chaperone function,” Journal of Biological Chemistry, vol. 284, no. 28, pp. 18801–18807, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Welsh and M. Gaestel, “Small heat-shock protein family: function in health and disease,” Annals of the New York Academy of Sciences, vol. 851, pp. 28–35, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. J. I. Clark and P. J. Muchowski, “Small heat-shock proteins and their potential role in human disease,” Current Opinion in Structural Biology, vol. 10, no. 1, pp. 52–59, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Sun and T. H. MacRae, “The small heat shock proteins and their role in human disease,” FEBS Journal, vol. 272, no. 11, pp. 2613–2627, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Haslbeck, T. Franzmann, D. Weinfurtner, and J. Buchner, “Some like it hot: the structure and function of small heat-shock proteins,” Nature Structural and Molecular Biology, vol. 12, no. 10, pp. 842–846, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. P. Arrigo, S. Simon, B. Gibert et al., “Hsp27 (HspB1) and αB-crystallin (HspB5) as therapeutic targets,” FEBS Letters, vol. 581, no. 19, pp. 3665–3674, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. D. Pollard and G. G. Borisy, “Cellular motility driven by assembly and disassembly of actin filaments,” Cell, vol. 112, no. 4, pp. 453–465, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. N. Lavoie, G. Gingras-Breton, R. M. Tanguay, and J. Landry, “Induction of Chinese hamster HSP27 gene expression in mouse cells confers resistance to heat shock. HSP27 stabilization of the microfilament organization,” Journal of Biological Chemistry, vol. 268, no. 5, pp. 3420–3429, 1993. View at Scopus
  12. J. N. Lavoie, E. Hickey, L. A. Weber, and J. Landry, “Modulation of actin-microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein 27,” Journal of Biological Chemistry, vol. 268, no. 32, pp. 24210–24214, 1993. View at Scopus
  13. Y. Zhu, S. O'Neill, J. Saklatvala, L. Tassi, and M. E. Mendelsohn, “Phosphorylated HSP27 associates with the activation-dependent cytoskeleton in human platelets,” Blood, vol. 84, no. 11, pp. 3715–3723, 1994. View at Scopus
  14. J. N. Lavoie, H. Lambert, E. Hickey, L. A. Weber, and J. Landry, “Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27,” Molecular and Cellular Biology, vol. 15, no. 1, pp. 505–516, 1995. View at Scopus
  15. J. Huot, F. Houle, D. R. Spitz, and J. Landry, “HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress,” Cancer Research, vol. 56, no. 2, pp. 273–279, 1996. View at Scopus
  16. J. Huot, F. Houle, F. Marceau, and J. Landry, “Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells,” Circulation Research, vol. 80, no. 3, pp. 383–392, 1997. View at Scopus
  17. J. Guay, H. Lambert, G. Gingras-Breton, J. N. Lavoie, J. Huot, and J. Landry, “Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27,” Journal of Cell Science, vol. 110, no. 3, pp. 357–368, 1997. View at Scopus
  18. S. Rousseau, F. Houle, J. Landry, and J. Huot, “P38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells,” Oncogene, vol. 15, no. 18, pp. 2169–2177, 1997. View at Scopus
  19. G. B. Schneider, H. Hamano, and L. F. Cooper, “In vivo evaluation of hsp27 as an inhibitor of actin polymerization: Hsp27 limits actin stress fiber and focal adhesion formation after heat shock,” Journal of Cellular Physiology, vol. 177, no. 4, pp. 575–584, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. A. I. Ibitayo, J. Sladick, S. Tuteja et al., “HSP27 in signal transduction and association with contractile proteins in smooth muscle cells,” American Journal of Physiology, vol. 277, no. 2, pp. G445–G454, 1999. View at Scopus
  21. C. Schäfer, P. Clapp, M. J. Welsh, R. Benndorf, and J. A. Williams, “HSP27 expression regulates CCK-induced changes of the actin cytoskeleton in CHO-CCK-A cells,” American Journal of Physiology, vol. 277, no. 6, pp. C1032–C1043, 1999. View at Scopus
  22. S. K. Van Why, A. S. Mann, T. Ardito et al., “Hsp27 associates with actin and limits injury in energy depleted renal epithelia,” Journal of the American Society of Nephrology, vol. 14, no. 1, pp. 98–106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Pichon, M. Bryckaert, and E. Berrou, “Control of actin dynamics by p38 MAP kinase—Hsp27 distribution in the lamellipodium of smooth muscle cells,” Journal of Cell Science, vol. 117, no. 12, pp. 2569–2577, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. R. L. During, B. G. Gibson, W. Li et al., “Anthrax lethal toxin paralyzes actin-based motility by blocking Hsp27 phosphorylation,” EMBO Journal, vol. 26, no. 9, pp. 2240–2250, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. B. M. Doshi, L. E. Hightower, and J. Lee, “The role of Hsp27 and actin in the regulation of movement in human cancer cells responding to heat shock,” Cell Stress and Chaperones, vol. 14, no. 5, pp. 445–457, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Miron, M. Wilchek, and B. Geiger, “Characterization of an inhibitor of actin polymerization in vinculin-rich fraction of turkey gizzard smooth muscle,” European Journal of Biochemistry, vol. 178, no. 2, pp. 543–553, 1988. View at Scopus
  27. B. Lelj-Garolla and A. G. Mauk, “Self-association of a small heat shock protein,” Journal of Molecular Biology, vol. 345, no. 3, pp. 631–642, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. H. E. White, E. V. Orlova, S. Chen et al., “Multiple distinct assemblies reveal conformational flexibility in the small heat shock protein Hsp26,” Structure, vol. 14, no. 7, pp. 1197–1204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. J. D. Pardee, “Purification of muscle actin,” Methods in Enzymology, vol. 85, pp. 164–181, 1982. View at Publisher · View at Google Scholar
  30. T. W. Houk and K. and Ue, “The measurement of actin concentration in solution: a comparison of methods,” Analytical Biochemistry, vol. 62, no. 1, pp. 66–74, 1974. View at Scopus
  31. M. P. Bova, H. S. Mchaourab, Y. Han, and B. K. K. Fung, “Subunit exchange of small heat shock proteins. Analysis of oligomer formation of αA-crystallin and Hsp27 by fluorescence resonance energy transfer and site-directed truncations,” Journal of Biological Chemistry, vol. 275, no. 2, pp. 1035–1042, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. P. K. Smith, R. I. Krohn, and G. T. Hermanson, “Measurement of protein using bicinchoninic acid,” Analytical Biochemistry, vol. 150, no. 1, pp. 76–85, 1985.
  33. F. G. Prendergast, M. Meyer, G. L. Carlson, S. Iida, and J. D. Potter, “Synthesis, spectral properties, and use of 6-acryloyl-2-dimethylaminonaphthalene (Acrylodan). A thiol-selective, polarity-sensitive fluorescent probe,” Journal of Biological Chemistry, vol. 258, no. 12, pp. 7541–7544, 1983. View at Scopus
  34. T. Kouyama and K. Mihashi, “Fluorimetry study of N-(1-pyrenyl)iodoacetamide-labelled F-actin. Local structural change of actin protomer both on polymerization and on binding of heavy meromyosin,” European Journal of Biochemistry, vol. 114, no. 1, pp. 33–38, 1981. View at Scopus
  35. E. P. Morris and S. S. Lehrer, “Troponin-tropomyosin interactions. Fluorescence studies of the binding of troponin, troponin T, and chymotryptic troponin T fragments to specifically labeled tropomyosin,” Biochemistry, vol. 23, no. 10, pp. 2214–2220, 1984. View at Scopus
  36. C. L. Drum, S. Z. Yan, R. Sarac et al., “An extended conformation of calmodulin induces interactions between the structural domains of adenylyl cyclase from Bacillus anthracis to promote catalysis,” Journal of Biological Chemistry, vol. 275, no. 46, pp. 36334–36340, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. W. F. Stafford III, “Boundary analysis in sedimentation velocity experiments,” Methods in Enzymology, vol. 240, pp. 478–501, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Xu, J. F. Casella, and T. D. Pollard, “Effect of capping protein, CapZ, on the length of actin filaments and mechanical properties of actin filament networks,” Cell Motility and the Cytoskeleton, vol. 42, no. 1, pp. 73–81, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. S. S. Lehrer, “Pyrene excimer fluorescence as a probe of protein conformational change,” Sub-cellular biochemistry, vol. 24, pp. 115–132, 1995. View at Scopus
  40. S. S. Lehrer, “Intramolecular pyrene excimer fluorescence: a probe of proximity and protein conformational change,” Methods in Enzymology, vol. 278, pp. 286–295, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. A. R. Berengian, M. Parfenova, and H. S. McHaourab, “Site-directed spin labeling study of subunit interactions in the α- crystallin domain of small heat-shock proteins. Comparison of the oligomer symmetry in αA-crystallin, HSP 27, and HSP 16.3,” Journal of Biological Chemistry, vol. 274, no. 10, pp. 6305–6314, 1999. View at Publisher · View at Google Scholar · View at Scopus
  42. H. S. Mchaourab, A. R. Berengian, and H. A. Koteiche, “Site-directed spin-labeling study of the structure and subunit interactions along a conserved sequence in the α-crystallin domain of heat- shock protein 27. Evidence of a conserved subunit interface,” Biochemistry, vol. 36, no. 48, pp. 14627–14634, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Zavialov, R. Benndorf, M. Ehrnsperger et al., “The effect of the intersubunit disulfide bond on the structural and functional properties of the small heat shock protein Hsp25,” International Journal of Biological Macromolecules, vol. 22, no. 3-4, pp. 163–173, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. A. V. Zavialov, M. Gaestel, T. Korpela, and V. P. Zav'Yalov, “Thiol/disulfide exchange between small heat shock protein 25 and glutathione,” Biochimica et Biophysica Acta, vol. 1388, no. 1, pp. 123–132, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Benndorf, K. Hayess, S. Ryazantsev, M. Wieske, J. Behlke, and G. Lutsch, “Phosphorylation and supramolecular organization of murine small heat shock protein HSP25 abolish its actin polymerization-inhibiting activity,” Journal of Biological Chemistry, vol. 269, no. 32, pp. 20780–20784, 1994. View at Scopus
  46. C. Le Clainche, S. P. Dwivedi, D. Didry, and M. F. Carlier, “Vinculin is a dually regulated actin filament barbed end-capping and side-binding protein,” Journal of Biological Chemistry, vol. 285, no. 30, pp. 23420–23432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Wang, R. C. Robinson, and L. D. Burtnick, “The structure of native G-actin,” Cytoskeleton, vol. 67, no. 7, pp. 456–465, 2010. View at Publisher · View at Google Scholar · View at Scopus